Vanadocene dichloride induces apoptosis in HeLa cells through depolymerization of microtubules and inhibition of Eg5
Susobhan Mahanty1, Darpan Raghav1, Krishnan Rathinasamy2
1School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, 673601, India.
Abstract:
Vanadocene dichloride (VDC), a vanadium containing metallocene dihalide exhibits promising anticancer activity. However, its mechanism of action remains elusive as several diverse targets and pathways have been proposed for its anticancer activity. In this study, we observed that VDC inhibited the proliferation of mammalian cancer cells and induced apoptotic cell death by altering the mitochondrial membrane potential and the expression of bcl2 and bax. Probing further into its anticancer mechanism, we found that VDC caused depolymerization of interphase microtubules and blocked the cells at mitosis with considerable proportion of cells exhibiting monopolar spindles. The reassembly of cold depolymerized microtubules was strongly inhibited in the presence of 10 μM VDC. VDC perturbed the microtubule-kinetochore interactions during mitosis as indicated by the absence of cold stable spindle microtubules in the cells treated with 20 μM VDC. Using goat brain tubulin, we found that VDC inhibited the steady-state polymer mass of microtubules and bound to tubulin at a novel site with a Kd of 9.71 ± 0.19 μM and perturbed the secondary structure of tubulin dimer. In addition, VDC was also found to bind to the mitotic kinesin Eg5 and inhibit its basal as well as microtubule stimulated ATPase activity. The results suggest that disruption of microtubule assembly dynamics and inhibition of the ATPase activity of Eg5 could be a plausible mechanism for the antiproliferative and antimitotic activity of VDC.Graphic abstract.
Insights
Vanadocene dichloride (VDC) inhibits cancer cell proliferation and induces apoptosis by disrupting microtubule dynamics and inhibiting Eg5 motor protein activity, revealing its anticancer mechanism.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Vanadocene dichloride (VDC) is a vanadium metallocene dihalide with demonstrated anticancer potential.
- The precise mechanism of VDC's anticancer activity is not fully understood, with various targets and pathways proposed.
Purpose of the Study:
- To elucidate the mechanism of action behind vanadocene dichloride's (VDC) antiproliferative and apoptotic effects on mammalian cancer cells.
- To investigate VDC's impact on cellular processes, including mitochondrial function, microtubule dynamics, and key mitotic proteins.
Main Methods:
- Assessed VDC's effects on cancer cell proliferation and apoptosis, including mitochondrial membrane potential and bcl2/bax expression.
- Analyzed VDC's impact on microtubule polymerization, depolymerization, and microtubule-kinetochore interactions.
- Investigated VDC's direct binding to tubulin and its effect on microtubule assembly dynamics.
- Examined VDC's interaction with and inhibition of the mitotic kinesin Eg5 ATPase activity.
Main Results:
- VDC inhibited cancer cell proliferation and induced apoptosis via mitochondrial pathways.
- VDC caused microtubule depolymerization, mitotic arrest with monopolar spindles, and inhibited microtubule reassembly.
- VDC bound to tubulin at a novel site, inhibiting microtubule polymerization and altering tubulin structure.
- VDC inhibited the ATPase activity of the mitotic kinesin Eg5.
Conclusions:
- VDC's anticancer activity stems from its disruption of microtubule assembly dynamics.
- Inhibition of Eg5 kinesin ATPase activity by VDC contributes to its antimitotic effects.
- Combined disruption of microtubule dynamics and Eg5 inhibition presents a plausible mechanism for VDC's antiproliferative and antimitotic actions.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Anaphase Promoting Complex
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway


